Skip to content

Clinical trials

Lung Diseases, Interstitial trials in Chile

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Country / region: Chile Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20172
20192
20201
20211
20225
20232
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting3
Recruiting2
Terminated2
Unknown status2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim4
United Therapeutics4
Bristol-Myers Squibb2
Contineum Therapeutics1
Gilead Sciences1
Hospital do Coracao1
Kyntra Bio1
Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1
Thorax National Institute1
Zura Bio Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial17
Idiopathic Pulmonary Fibrosis8
Pulmonary Fibrosis5
Scleroderma, Diffuse3
Idiopathic Interstitial Pneumonias2
Alveolitis, Extrinsic Allergic1
Arthritis, Rheumatoid1
Autoimmune Diseases1
Connective Tissue Diseases1
Fibrosis1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.